Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
Just nowPress Release Apr 29 2026
17m agoColgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
44m agoNavios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
44m agoAddex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
44m agoFiverr Announces First Quarter 2026 Results
Exelixis Inc logo

Exelixis Inc

About

Exelixis Inc (NASDAQ:EXEL) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026
Feb 24 2026
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
Feb 10 2026
Exelixis Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
Feb 2 2026
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
Jan 27 2026
Exelixis to Release Fourth Quarter and Fiscal Year 2025 Financial Results on Tuesday, February 10, 2026

Financials

Revenue
$2.32 B
Market Cap
$11.76 B
P/E Ratio
15.78
EPS
2.78

Community Chat

Ask AI

6ix6ix